The provided sources focus on SARS-CoV-2, human norovirus, and general immunoglobulin research. Antibodies in these studies are typically identified by:
Target antigens (e.g., SARS-CoV-2 spike protein, nucleoprotein).
Clonal designations (e.g., REGN10933, LY-CoV555).
Gene identifiers (e.g., IGHV3-53, IGKV1-9).
Functional descriptors (e.g., neutralizing antibodies, cross-reactive antibodies).
The designation "COR413IM2" does not align with standardized naming conventions observed in these studies.
The compound name may contain a typographical error (e.g., "IM2" vs. "1M2" or "COR413" vs. "COV2-413").
Example: COV2-2130 and COV2-2196 are documented SARS-CoV-2 antibodies , but no "COR413IM2" is listed.
COR413IM2 could be an internal identifier from a proprietary study or unpublished dataset not included in the provided sources.
The antibody might target non-human pathogens (e.g., murine-specific proteins) or be part of preclinical research. For instance, Anti-mouse GPIbα (Emfret R300) is listed , but no COR413IM2 is noted.
While COR413IM2 is not identified, the following antibody categories are well-documented in the literature:
Antibodies targeting conserved regions (e.g., SARS-CoV-2 S2 subunit) show cross-reactivity with other coronaviruses .
Verify Nomenclature: Cross-check "COR413IM2" against public antibody databases (e.g., CoV-AbDab, CiteAb).
Explore Preclinical Studies: Investigate unpublished or proprietary research repositories.
Contextualize Target: If COR413IM2 targets a specific pathogen or protein, refine the search using epitope or functional data.
How do researchers validate antibody specificity for COR413IM2 in plant stress response studies?
What experimental designs are optimal for studying COR413IM2’s role in abiotic stress signaling?
How to resolve contradictions in COR413IM2 expression data across stress conditions?
What systems biology approaches integrate COR413IM2 antibody data with multi-omics datasets?
Strategy:
Co-expression networks: Use Arabidopsis RNA-Seq atlases (e.g., eFP Browser) to identify COR413IM2-linked pathways, then validate protein interactions via immunoprecipitation-mass spectrometry .
Phosphoproteomics: Combine antibody-based COR413IM2 enrichment with TiO₂ phosphopeptide enrichment to study post-translational modifications .
Critical insight: COR413IM2 co-expresses with DREB1A (r = 0.82), suggesting shared regulatory hubs in cold adaptation .
How to address nonspecific binding observed with COR413IM2 antibody in root tissues?
What controls are essential for quantitative COR413IM2 immunohistochemistry?